Member Info for researcher1

managed the last chunk of my ISA today...

yup - or some news leakage on slimbiome....

the comparative MCAPs don't make much sense. Money flowing back this way now...

quite right to think that way as a LTH.

I wouldn't expect the revenue updates to be stellar for a year or so - though they will have a very steep trajectory. There will be upward SP pressure due to potential contracts/takeover interest, especially when Nasdaq appears on the horizon.

plenty now being bought this morning after the quick in-and-outs to take advantage of SBTX (me included, but only £5K)

by year end?! my money is on 184+!

but as usual the market gives little notice to an RNSR - read it carefully please!

more irrefutable evidence of Angle's superiority to the market leader - watch out multibillion liquid biopsy world, here we come!

I think we can all forgive him in our collective excitement....OPTI absolutely needs to rise if SBTX goes higher - we know there is a see-saw dynamic between the two - not always predictable, however.

I have a 50:50 split, which still gives me a lot more SBTX exposure, technically...

nice find - could be the trigger to pull those shorts down....

Seeing that Ted sold all his opti shares just before the rise makes the weekend beverages taste even better

easy chaps...there's room for all opinions here. The FDA could ask for further clarifications I suppose, but surely only within the sections that the company has been working on? The implication was that the remainder of the submission had been okayed. So I'm prepared for a very short final request for specific clarification, but nothing major, or time-consuming. Could be proved wrong, obviously.

that 170 was before a fair bit of dilution scot, so not workable as a current target or resistance level. Whether 120 is feasible before FDA approval may depend on the size of pharma contracts - we should get those next week or early the following, judging by how the company is carefully spreading out news.... It is possible that expectation alone will drive the sp there, but I sense many are waiting to push the button as and when FDA arrives... after which there will then be quite a bit of argy-bargy for a few weeks - I actually have no idea how far that kind of excitement could push the sp.

I don't see that happening with Angle Jake. There may well be pressured interest from the likes of Thermo Fisher, but Newland has an enormous shareholding as a disincentive to sell low. The company has also conducted itself with probity over the years, so there's no reason to suppose they are not working for the good of all stakeholders.

thanks, yes saw that elsewhere, huge sales pipeline in Asia....

because it would be this year rather than in the future Phantom, and I'm sure he would be retained with appropriate SP related recompense

it is a bit low for the IP Tom, but then so is the current 85p! the market values current circumstances - but you are right that after FDA approval it could become a case of 'pick a number' for a big player (if they could keep AN and the Angle team on board, due to pipeline developments...).

there appears to be a belief that if everyone keeps repeating "should see 60p today" it will make it happen....